Literature DB >> 24745349

Central nervous system toxicities of chemotherapeutic agents.

Parvin F Peddi1, Srinivas Peddi, Edgardo S Santos, Daniel Morgensztern.   

Abstract

Although there has been a significant progress in the recognition and management of the most common chemotherapy side effects, there is limited data on CNS toxicities. Since CNS toxicities can cause significant morbidity and delay or interruption of potentially effective therapies, there is a need for better understanding, early detection, prompt discontinuation of the offending drug, and use of antidotes when available. This review describes neurological toxicities from some of the commonly used chemotherapy agents.

Entities:  

Keywords:  CNS; antidotes; chemotherapy; encephalopathy; posterior reversible encephalopathic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24745349     DOI: 10.1586/14737140.2014.911089

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  9 in total

1.  The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study.

Authors:  A Zarabla; S Ungania; A Cacciatore; A Maialetti; G Petreri; A Mengarelli; A Spadea; F Marchesi; D Renzi; Svitlana Gumenyuk; L Strigari; Marta Maschio
Journal:  Funct Neurol       Date:  2017 Oct/Dec

2.  Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome.

Authors:  Ting-An Lin; Jyh-Pyng Gau; Yao-Chung Liu; Po-Shen Ko; Hao-Yuan Wang; Sheng-Hsuan Chien; Chia-Jen Liu; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu
Journal:  Int J Hematol       Date:  2019-03-12       Impact factor: 2.490

Review 3.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

4.  Early Effects of Cyclophosphamide, Methotrexate, and 5-Fluorouracil on Neuronal Morphology and Hippocampal-Dependent Behavior in a Murine Model.

Authors:  Julie E Anderson; Madison Trujillo; Taylor McElroy; Thomas Groves; Tyler Alexander; Frederico Kiffer; Antiño R Allen
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

5.  Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms.

Authors:  Peter W Szlosarek; Melissa M Phillips; Iuliia Pavlyk; Jeremy Steele; Jonathan Shamash; James Spicer; Sanjeev Kumar; Simon Pacey; Xiaoxing Feng; Amanda Johnston; John Bomalaski; Graeme Moir; Kelvin Lau; Stephen Ellis; Michael Sheaff
Journal:  JTO Clin Res Rep       Date:  2020-09-03

6.  Suicide attempt induced by drug-induced leukoencephalopathy: A case report.

Authors:  Ryo Maehara; Yasushi Kawamata; Motoshi Ichikawa; Kinuko Mitani; Norio Yasui-Furukori; Kazutaka Shimoda
Journal:  Neuropsychopharmacol Rep       Date:  2021-10-15

Review 7.  Mechanisms of Chemotherapy-Induced Neurotoxicity.

Authors:  Halina Was; Agata Borkowska; Ana Bagues; Longlong Tu; Julia Y H Liu; Zengbing Lu; John A Rudd; Kulmira Nurgali; Raquel Abalo
Journal:  Front Pharmacol       Date:  2022-03-28       Impact factor: 5.810

8.  Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate.

Authors:  Ka Young Lim; Seong-Ik Kim; Hyunhee Kim; Jeongwan Kang; Jin Woo Park; Jae Kyung Won; Dong-Yeop Shin; Sung-Hye Park
Journal:  BMC Neurol       Date:  2022-08-03       Impact factor: 2.903

9.  Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size.

Authors:  Marady Hun; Min Xie; Zhou She; Amin S Abdirahman; Cuifang Li; Feifeng Wu; Senlin Luo; Phanna Han; Rithea Phorn; Pan Wu; Haiyan Luo; Keke Chen; Jidong Tian; Wuqing Wan; Chuan Wen
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.